Zai Lab Ltd (ZLAB): Total Assets
$1.17B
As of 2025-12-31
$1.07B
As of 2026-06-30
-1.3%
3-year compound annual growth
-2.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.17B | -1.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.19B | +14.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $1.04B | -15.1% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $1.22B | -24.2% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $1.61B | +24.1% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $1.30B | +265.4% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $355.15M | +17.6% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $301.99M | +21.0% | 2020-04-29, Balance as of period end |
| 2017-12-31 | $249.63M | +180.8% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $88.91M | n/a | 2018-04-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $1.17B | -1.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.64B | +25.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $501.60M | +15.1% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $8.54B | -30.8% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
Compare ZLAB, NATR, TVTX, BBIO side by side · Screen every company in Pharmaceutical Preparations ↗